First AD

Second AD

Pruritus Control With PPAR Agonists in PBC

Video content above is prompted by the following:

Pruritus is a debilitating symptom experienced by over 80% of patients with cholestatic liver diseases, such as PBC. What is the role of effectively treating pruritus in the long-term management of PBC?

Clinical

clinical page is a resource for content on every specialty, disease, and topic available on our medical news site.

Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Video Series

Expanding Treatment Options for Primary Biliary Cholangitis with Novel Therapies

Effective management of pruritus in patients with primary biliary cholangitis (PBC) is crucial for improving quality of life and adherence to treatment regimens. Pruritus, a common and distressing symptom in cholestatic liver diseases, can significantly impact patients' physical and mental well-being. Addressing this symptom can lead to better patient outcomes and may prevent complications associated with chronic itching. Treatment strategies include pharmacological interventions and lifestyle modifications, tailored to individual patient needs. Long-term management requires a comprehensive approach, integrating symptom control with disease-modifying therapies.

The panel of experts discuss the role of effectively treating pruritus, a common and debilitating symptom in over 80% of patients with cholestatic liver diseases like primary biliary cholangitis (PBC), and its importance in the long-term management of the disease.